Frontiers in Immunology (Aug 2022)

T cell perturbations persist for at least 6 months following hospitalization for COVID-19

  • Melissa Govender,
  • Francis R. Hopkins,
  • Robin Göransson,
  • Robin Göransson,
  • Cecilia Svanberg,
  • Esaki M. Shankar,
  • Maria Hjorth,
  • Maria Hjorth,
  • Åsa Nilsdotter-Augustinsson,
  • Johanna Sjöwall,
  • Sofia Nyström,
  • Sofia Nyström,
  • Marie Larsson

DOI
https://doi.org/10.3389/fimmu.2022.931039
Journal volume & issue
Vol. 13

Abstract

Read online

COVID-19 is being extensively studied, and much remains unknown regarding the long-term consequences of the disease on immune cells. The different arms of the immune system are interlinked, with humoral responses and the production of high-affinity antibodies being largely dependent on T cell immunity. Here, we longitudinally explored the effect COVID-19 has on T cell populations and the virus-specific T cells, as well as neutralizing antibody responses, for 6-7 months following hospitalization. The CD8+ TEMRA and exhausted CD57+ CD8+ T cells were markedly affected with elevated levels that lasted long into convalescence. Further, markers associated with T cell activation were upregulated at inclusion, and in the case of CD69+ CD4+ T cells this lasted all through the study duration. The levels of T cells expressing negative immune checkpoint molecules were increased in COVID-19 patients and sustained for a prolonged duration following recovery. Within 2-3 weeks after symptom onset, all COVID-19 patients developed anti-nucleocapsid IgG and spike-neutralizing IgG as well as SARS-CoV-2-specific T cell responses. In addition, we found alterations in follicular T helper (TFH) cell populations, such as enhanced TFH-TH2 following recovery from COVID-19. Our study revealed significant and long-term alterations in T cell populations and key events associated with COVID-19 pathogenesis.

Keywords